EWP
IDXX icon

Engrave Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Engrave Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-56
Closed -$18K – 230
2020
Q2 		$18K Buy
56
+23
+70% +$6.66K 0.02% 192
2020
Q1 		$7K Sell
33
-2
-6% -$522 0.01% 235
2019
Q4 		$9K Buy
+35
New +$9.22K 0.01% 312

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Engrave Wealth Partners's IDXX Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Idexx Laboratories (IDXX) in Q3 2020, closing a stake of 56 shares — an estimated $18K sold.

Engrave Wealth Partners first reported a position in IDXX in Q4 2019 and held it in 3 quarters. The position peaked at $18K in Q2 2020. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Idexx Laboratories position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 56 Idexx Laboratories shares in Q3 2020, an estimated $18K.
  • Engrave Wealth Partners first reported a position in Idexx Laboratories in Q4 2019 and held it in 3 quarters.
  • Engrave Wealth Partners's Idexx Laboratories position peaked at $18K in Q2 2020.
  • 846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.